[vc_row][vc_column width=”1/1″][vc_column_text]
[/vc_column_text][/vc_column][/vc_row]
Kategoria: Wydarzenia
[vc_row][vc_column width=”1/1″][vc_column_text]Philadelphia, Pennsylvania, USA
OncoArendi will present a poster on the Development of OATD-02, a novel arginase 1 and 2 inhibitor for cancer immunotherapy. (Poster Session B, Sunday Oct 29, 2017 12:30 PM – 4:00 PM, Hall E)
[/vc_column_text][/vc_column][/vc_row]
[vc_row][vc_column width=”1/1″][vc_column_text]OncoArendi will present a poster on the development of a novel arginase 1 and 2 inhibitor for cancer immunotherapy, on Sunday, 10th at 1PM. (link: OAT-1746 ESMO 2017)
[/vc_column_text][/vc_column][/vc_row]
[vc_row][vc_column width=”1/1″][vc_column_text]OncoArendi will present a poster on The Therapeutic Efficacy of OAT-889 (DualAMCase/CHIT1 Inhibitor) in Comparison to Montelukast in HDM-induced Model of Chronic Airway Inflammation in Mice, on Wednesday 13th, 10th at 8:30 AM. (link: Poster OAT-889 ERS 2017)
[/vc_column_text][/vc_column][/vc_row]
[vc_row][vc_column width=”1/1″][vc_column_text]The company presentation will take place on Tuesday, 20th of June, at 3:15 PM in Theatre 4.
[/vc_column_text][/vc_column][/vc_row]
[vc_row][vc_column width=”1/1″][vc_column_text]A poster will be presented on Monday, 22nd of May from 9AM (link: poster OAT-889 ATS 2017)
http://conference.thoracic.org
[/vc_column_text][/vc_column][/vc_row]